3500 ORAL Preliminary results from a phase II, randomized, double-blind study of sorafenib plus doxorubicin versus placebo plus doxorubicin in patients with advanced hepatocellular carcinoma

G.K. Abou Alfa; P. Johnson; J. Knox; J. Lacava; T. Leung; A. Mori; M.A. Leberre; D. Voliotis; L. Saltz

doi:10.1016/s1359-6349(07)71003-0

3500 ORAL Preliminary results from a phase II, randomized, double-blind study of sorafenib plus doxorubicin versus placebo plus doxorubicin in patients with advanced hepatocellular carcinoma

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)71003-0 ◽

2007 ◽

Vol 5 (4) ◽

pp. 259 ◽

Cited By ~ 26

Author(s):

G.K. Abou Alfa ◽

P. Johnson ◽

J. Knox ◽

J. Lacava ◽

T. Leung ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Blind Study ◽

Double Blind Study ◽

Advanced Hepatocellular Carcinoma ◽

Double Blind ◽

Preliminary Results

Download Full-text

Efficacy and Safety Results from a Phase 2, Randomized, Double-Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular Carcinoma

Clinical Drug Investigation ◽

10.1007/s40261-021-01063-0 ◽

2021 ◽

Author(s):

Baek-Yeol Ryoo ◽

Daniel H. Palmer ◽

Sook Ryun Park ◽

Lorenza Rimassa ◽

Debashis Sarker ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Blind Study ◽

Double Blind Study ◽

Advanced Hepatocellular Carcinoma ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind

Download Full-text

Faculty Opinions recommendation of A Phase II, randomized, double-blind study of zibotentan (ZD4054) in combination with carboplatin/paclitaxel versus placebo in combination with carboplatin/paclitaxel in patients with advanced ovarian cancer sensitive to platinum-based chemotherapy (AGO-OVAR 2.14).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969432.793470323 ◽

2013 ◽

Author(s):

Steve Plaxe ◽

Kristy Ward

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Advanced Ovarian Cancer ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Platinum Based Chemotherapy

Download Full-text

Benefits of immunonutrition in patients with head and neck cancer receiving chemoradiation: A phase II randomized, double-blind study

Clinical Nutrition ◽

10.1016/j.clnu.2021.12.035 ◽

2021 ◽

Author(s):

Tanadech Dechaphunkul ◽

Tippawan Arundon ◽

Ponpis Raungkhajon ◽

Rungarun Jiratrachu ◽

Sarayut Lucien Geater ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Blind Study ◽

Double Blind Study ◽

Double Blind

Download Full-text

Abstract OT1-1-01: LORELEI: A Phase II randomized, double-blind study of neoadjuvant letrozole plus taselisib (GDC-0032) versus letrozole plus placebo in postmenopausal women with ER-positive/HER2-negative, early stage breast cancer

10.1158/1538-7445.sabcs14-ot1-1-01 ◽

2015 ◽

Author(s):

Cristina Saura ◽

Evandro de Azambuja ◽

Peter Dubsky ◽

Mafalda Oliveira ◽

Kamal S Saini ◽

...

Keyword(s):

Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Early Stage ◽

Blind Study ◽

Early Stage Breast Cancer ◽

Double Blind Study ◽

Double Blind ◽

Er Positive

Download Full-text

A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)

BMC Cancer ◽

10.1186/s12885-019-5805-z ◽

2019 ◽

Vol 19 (1) ◽

Author(s):

Roche Kapoor ◽

Matthew P. Deek ◽

Riley McIntyre ◽

Natasha Raman ◽

Megan Kummerlowe ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Radical Prostatectomy ◽

Phase Ii ◽

Blind Study ◽

Double Blind Study ◽

Recurrent Prostate Cancer ◽

Double Blind ◽

Salvage Radiation Therapy

Download Full-text

Oncoxin-Viusid with Radiotherapy and Chemotherapy in Patients with Head and Neck Cancer: Results from a Phase II, Randomised, Double-Blind Study

Journal of Cancer Science & Therapy ◽

10.4172/1948-5956.1000562 ◽

2018 ◽

Vol 10 (10) ◽

Author(s):

Ivonne Chon Rivas ◽

Jose Alert Silva ◽

Gagmar Alfonso ◽

Helga Candanedo ◽

Yelena Cuervo ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Blind Study ◽

Double Blind Study ◽

Double Blind

Download Full-text

A Randomized, Multi-Center, Parallel-Group, Phase Ii(Single Blind)/Iii(Double Blind) Study to Evaluate the Efficacy and Safety of Green Cross Pegteograstim (Gcpgc) on Chemotherapy-Induced Neutropenia Compared to Pegfilgrastim

Annals of Oncology ◽

10.1093/annonc/mdu356.21 ◽

2014 ◽

Vol 25 ◽

pp. iv524

Author(s):

M.H. Lee ◽

K.H. Lee ◽

J. Kim ◽

K.U. Park ◽

I. Park ◽

...

Keyword(s):

Phase Ii ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Double Blind ◽

Parallel Group ◽

Chemotherapy Induced Neutropenia ◽

Single Blind

Download Full-text

FRI0331 Apremilast for the treatment of behçet’s syndrome: a phase ii randomized, placebo-controlled, double-blind study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.1458 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A486.2-A486 ◽

Cited By ~ 1

Author(s):

G. Hatemi ◽

M. Melikoglu ◽

R. Tunc ◽

C. Korkmaz ◽

B. T. Ozturk ◽

...

Keyword(s):

Phase Ii ◽

Blind Study ◽

Double Blind Study ◽

Behçet’S Syndrome ◽

Double Blind ◽

Behçet's Syndrome ◽

Behcet’S Syndrome ◽

Behcet's Syndrome

Download Full-text

Phase II, clinical evaluation of 2% polyphenone (green tea extract) in a hydrophilic gel to assess improvement in damaged and premature aged facial skin. a placebo-controlled, double-blind study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2003.10.103 ◽

2004 ◽

Vol 50 (3) ◽

pp. P25 ◽

Cited By ~ 2

Author(s):

Tanweer A Syed ◽

Wendy H. Wong ◽

Seyed Ali Ahmad ◽

Raza Aly

Keyword(s):

Green Tea ◽

Phase Ii ◽

Clinical Evaluation ◽

Green Tea Extract ◽

Blind Study ◽

Double Blind Study ◽

Facial Skin ◽

Double Blind ◽

Tea Extract ◽

Hydrophilic Gel

Download Full-text

803 EFFICACY, SAFETY AND IMPACT ON QUALITY OF LIFE OF SORAFENIB IN ELDERLY PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA. PRELIMINARY RESULTS OF A PHASE II STUDY

Journal of Hepatology ◽

10.1016/s0168-8278(09)60805-9 ◽

2009 ◽

Vol 50 ◽

pp. S294

Author(s):

G. Mantovani ◽

E. Massa ◽

C. Spiga ◽

L. Chessa ◽

C. Madeddu ◽

...

Keyword(s):

Quality Of Life ◽

Hepatocellular Carcinoma ◽

Elderly Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Hepatocellular Carcinoma ◽

Preliminary Results

Download Full-text